HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece

Nov.15.2024
 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
HAYATI launches new Hayati® Mini Ultra disposable vape in UK, featuring two 2ml transparent e-liquid pods with different flavours, allowing users to switch flavours by twisting the mouthpiece, providing approximately 1500 puffs.

Disclaimer

 

  • This article is intended solely for internal industry communication and does not constitute an endorsement of any brand or product.
  • The images presented in this article are for factual illustration purposes only and should not be interpreted as advertisements for any product.
  • Access to this article is prohibited for minors.

 

Recently, 2Firsts noticed that the vape brand HAYATI has launched the Hayati® Mini Ultra vape in the UK market. The product features two 2ml pods, compliant with TPD standards, and offers approximately 1500 puffs.

 

Specifically, the product features of the Hayati® Mini Ultra include:

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
Hayati® Mini Ultra parameters | Plotting: 2Firsts

 

The main feature of the Hayati® Mini Ultra is its ability to hold two 2ml transparent e-liquid pods with different flavours, allowing users to switch between the two flavours by twisting the mouthpiece.

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
Hayati® Mini Ultra | Image source: vapesourcing

 

Previously, the HAYATI brand launched the Hayati® PRO Ultra vape, which also features a similar twist mouthpiece design. However, this product is equipped with two 12ml e-liquid pods and claims to provide approximately 15,000 puffs.

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
HAYATI® Pro Ultra Disposable 15,000 Puffs|Image Source: HAYATI Official Website

 

It is worth noting that the Hayati® Mini Ultra does not feature the electronic screen used in the Hayati® PRO Ultra for direct battery level display. Instead, it uses a color-changing "lotus-shaped" LED indicator to indirectly show the battery level.

 

Currently, the Hayati® Mini Ultra is available on the official HAYATI website and other well-known UK vape retailers like vapesourcing.uk, with the product page marked as "COMING SOON."

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
Hayati® Mini Ultra Product Page | Image Source: vapesourcing

 

According to the official HAYATI website, the HAYATI brand is owned by PAX Innovations (Shenzhen) Limited. All product registration applications with the UK Medicines and Healthcare Products Regulatory Agency (MHRA) are submitted by this company. The HAYATI website also references "PAX Manufacturing" and includes a link to the corresponding website.

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
PAX official website | Image source: PAX

 

The PAX official website states that the company was founded in Hong Kong in 2021. Its founder, Mr. He, is an experienced expert in the e-cigarette industry, dedicated to the research and innovation of e-cigarette products.

 

2Firsts will continue to track the latest products and market trends in disposable vapes, offering the public accurate and authoritative industry information.

 


 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

Philip Morris Loses Two European Nicotine Pouch Patents in a Month Following BAT Challenges Over Nicotine Release and Formulation Technology
Philip Morris Loses Two European Nicotine Pouch Patents in a Month Following BAT Challenges Over Nicotine Release and Formulation Technology
The European Patent Office (EPO) published an appeal decision on November 17, 2026, revoking Philip Morris Products S.A.'s European nicotine pouch patent EP 3773494, covering a formulation involving free-base nicotine, ion-exchange resin and a water content of at least 15%. The decision followed an opposition and appeal brought by British American Tobacco (BAT) entity Nicoventures Trading Limited. Philip Morris withdrew its approval of the patent text during the appeal, leading the EPO to revoke the patent. A separate European patent, EP 3809884, covering the distribution of nicotine between a pouch membrane and its internal composition, had been revoked on September 24 following a challenge from another BAT entity. The patents share a 2019 priority basis, while related European divisional applications also exist.
company
Nov.18 by 2Firsts Perspectives
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How are investors reassessing the global tobacco industry as nicotine markets evolve? In an interview with 2Firsts, Charlie Chen, Head of Research at CCB International Securities, forecasts annual growth of 30–50% for nicotine pouches, outpacing vaping and heated tobacco. He examines how regulatory enforcement, shifting market shares and new business models are influencing company valuations. The report also explores differences between multinational tobacco groups and Chinese companies, drawing on insights from the New Approaches Summit on profitability, investment strategies and industry consolidation.
Nov.11
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Japan Tobacco Inc. (JT) announced on November 12, 2026, that it had acquired the U.S. assets of nicotine pouch brand CLEW from Nevcore Innovations Inc., including trademarks, intellectual property, product formulations and a Premarket Tobacco Product Application (PMTA). CLEW, currently distributed through selected outlets in 13 U.S. states, will immediately join the JTI LIGGETT portfolio. The transaction follows JT's approximately $2.4 billion acquisition of U.S. cigarette maker Vector Group in 2024. JTI LIGGETT says its existing cigarette brands reach more than 160,000 U.S. retail stores. During the 2026 NACS Show in October, JTI LIGGETT booth staff told 2Firsts that the company had not yet launched nicotine pouches in the United States. Although Nevcore previously announced FDA acceptance of CLEW's PMTA, the brand is absent from the agency's current list of authorized nicotine pouch products. JT has not disclosed a retail expansion plan for CLEW.
Business
Nov.12